Polar lipids in serum, including lysophospholipids (LPLs) and free fatty acids (FFAs), have a broad range of biological activities and require a suitable method for their quantitative analysis. Conventional methods use multistep procedures to simultaneously purify and analyze polar lipids and non-polar lipids in serum. However, the methods could result in inaccurate quantifications of polar and/or non-polar lipids because compounds with different polarities have different behaviors in solvent extraction and mass spectrometric ionization. In this study, a method was designed to analyze polar lipids in serum based on the polarities of LPLs and FFAs. The method consisted of extraction without filtration and analysis of the crude extract without multistep purification. Fifty LPLs and 32 FFAs were detected in rat serum. The concentrations of LPLs (1272.1 μmole/L in female and 999.8 μmole/L in male) and FFAs (1910.9 μmole/L in female and 1651.4 μmole/L in male) were determined. Peak areas of MS ion in Extract Ion Chromatogram (EIC) were used for the quantification in this study. The approach of quantification should be perfectly suitable for precise quantification of a specific serum component by adding its isotope standard to the serum before extraction.
Get full access to this article
View all access options for this article.
References
1.
Croset M, Brossard N, Polette A, Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J345:61–67, 2000.
2.
Asaoka Y, Oka M, Yoshida K, Sasaki Y, Nishizuka Y. Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C. Proc Natl Acad Sci U S A89:6447–6451, 1992.
3.
Liebisch G, Drobnik W, Lieser B, Schmitz G. High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clin Chem48:2217–2224, 2002.
4.
Tokumura A, Kanaya Y, Kitahara M, Miyake M, Yoshioka Y, Fukuzawa K. Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits. J Lipid Res43:307–315, 2002.
5.
Okita M, Gaudette DC, Mills GB, Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients. Int J Cancer71:31–34, 1997.
6.
Mehta D, Gupta S, Gaur SN, Gangal SV, Agrawal KP. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis142:157–161, 1990.
7.
Ikeda Y, Fukuoka S, Kito M. Increase in lysophosphatidylethanolamine in the cell membrane upon the regulated exocytosis of pancreatic acinar AR42J cell. Biosci Biotech Biochem61:207–209, 1997.
8.
van der Bend RL, Brunner J, Jalink K, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J11:2495–2501, 1992.
9.
van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell59:45–54, 1989.
10.
Valone FH. Interrelationship among platelet-activating factor binding and metabolism and induction of platelet activation. In: Jamieson GA, Ed. Platelet Membrane Receptors: Molecular biology, immunology, biochemistry, and pathology. New York: Liss, p319, 1988.
11.
Shukla SD, Morrison WJ. Platelet activating factor receptor occupancy in relation to activation and desensitization of phosphoinositide specific phospholipase C. In: Jamieson GA, Ed. Platelet Membrane Receptors: Molecular biology, immunology, biochemistry, and pathology. New York: Liss, p341, 1988.
12.
Xu Y, Fang XJ, Casey G, Mills GB. Lysophospholipids activate ovarian and breast cancer cells. Biochem J309:933–940, 1995.
13.
Falasca M, Iurisci C, Carvelli A, Sacchetti A, Corda D. Release of the mitogen lysophosphatidylinositol from H-ras transformed fibroblasts: a possible mechanism of autocrine control of cell proliferation. Oncogene16:2357–2365, 1998.
14.
Tamori-Natori Y, Horigome K, Inoue K, Nojima S. Metabolism of lysophosphatidylserine, a potentiator of histamine release in rat mast cells. J Biochem (Tokyo)100:581–590, 1986.
15.
Besterman JM, Domanico PL. Association and metabolism of exogenously-derived lysophosphatidylcholine by cultured mammalian cells: kinetics and mechanisms. Biochemistry31:2046–2056, 1992.
16.
Morash SC, Cook HW, Spence MW. Lysophosphatidylcholine as an intermediate in phosphatidylcholine metabolism and glycerophosphocholine synthesis in cultured cells: an evaluation of the roles of 1-acyl-and 2-acyl-lysophosphatidylcholine. Biochim Biophys Acta1004:221–229, 1989.
17.
Yoshida K, Asaoka Y, Nishizuka Y. Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acids. Proc Natl Acad Sci U S A89:6443–6446, 1992.
18.
Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab1:245–258, 2005.
19.
Misra UK. Isolation of lysophosphatidylethanolamine from human serum. Biochim Biophys Acta106:371–378, 1965.
20.
Corr PB, Snyder DW, Lee BI, Gross RW, Keim CR, Sobel BE. Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol243:H187–H195, 1982.
21.
Wang WQ, Gustafson A. One-dimensional thin-layer chromatographic separation of phospholipids and lysophospholipids from tissue lipid extracts. J Chromatogr581:139–142, 1992.
22.
Yokoyama K, Shimizu F, Setaka M. Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography. J Lipid Res41:142–147, 2000.
23.
Bernhard W, Linck M, Creutzburg H, Postle AD, Arning A, Martin-Carrera I, Sewing KF. High-performance liquid chromatographic analysis of phospholipids from different sources with combined fluorescence and ultraviolet detection. Anal Biochem220:172–180, 1994.
24.
Guan Z, Grunler J, Piao S, Sindelar PJ. Separation and quantitation of phospholipids and their ether analogues by high-performance liquid chromatography. Anal Biochem297:137–143, 2001.
25.
Lesnefsky EJ, Stoll MS, Minkler PE, Hoppel CL. Separation and quantitation of phospholipids and lysophospholipids by high-performance liquid chromatography. Anal Biochem285:246–254, 2000.
26.
Seijo L, Merchant TE, van der Ven LTM, Minsky BD, Glonek T. Meningioma phospholipid profiles measured by 31P nuclear magnetic resonance spectroscopy. Lipids29:359–364, 1994.
27.
Merchant TE, Lass JH, Meneses P, Greiner JV, Glonek T. Human crystalline lens phospholipids analysis with age. Invest Ophthalmol Vis Sci32:549–555, 1991.
28.
Brügger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci U S A94:2339–2344, 1997.
29.
Haroldsen PE, Murphy RC. Analysis of phospholipid molecular species in rat lung as dinitrobenzoate diglycerides by electron capture negative chemical ionization mass spectrometry. Biomed Environ Mass Spectrom14:573–578, 1987.
30.
Fang N, Yu S, Badger TM. LC-MS/MS analysis of lysophospholipids associated with soy protein isolate. J Agric Food Chem51:6676–6682, 2003.
31.
Fang N, Yu S, Badger TM. Comprehensive phytochemical profile of soy protein isolate. J Agric Food Chem52:4012–4020, 2003.
32.
Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr123:1939–1951, 1993.
33.
Murpht RC, Fiedler J, Hevko J. Analysis of nonvolatile lipids by mass spectrometry. Chem Rev101:479–526, 2001.
34.
Yu S, Fang N, Li Q, Zhang J, Luo H, Ronis M, Badger TM. In vitro actions on human cancer cells and the liquid chromatography-mass spectrometry/mass spectrometry fingerprint of phytochemicals in rice protein isolate. J Agric Food Chem54:4482–4492, 2006.
35.
Yoon H, Kim H, Cho S. Quantitative analysis of acyl-lysophosphatidic acid in plasma using negative ionization tandem mass spectrometry. J ChromatogrB788:85–92, 2003.
36.
Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J291:677–680, 1993.
